All In MedTech

FDA Clearance Tracker · P150003

SYNERGY EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Oct 2, 2015 (this decision)Source: openFDAMethods & limitations

PMA

The decision

FDA number
P150003
Device name
SYNERGY EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
Applicant location
Maple Grove, MN
Received
Jan 15, 2015
Decided
Oct 2, 2015
Decision
Approved
Supplements
109 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code NIQ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE SYNERGY EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM. THIS DEVICE IS INDICATED FOR IMPROVING LUMINAL DIAMETER IN PATIENTS WITH SYMPTOMATIC HEART DISEASE, STABLEANGINA, UNSTABLE ANGINA, NON-ST ELEVATION MI OR DOCUMENTED SILENT ISCHEMIA DUE TO ATHEROSCLEROTIC LESIONS IN NATIVE CORONARY ARTERIES >=2.25 MM TO <=4.0 MM IN DIAMETER IN LESIONS <=34 MM IN LENGTH.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code NIQ. The earliest in FDA's data is P020026, decided Apr 24, 2003.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Boston Scientific Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.